Establishment Labs Holdings Aktie [WKN DE: A2JRE4 / ISIN: VGG312491084]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Establishment Labs Holdings Inc Registered Shs

28.02.23		Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference (Businesswire)
27.02.23		Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results (Businesswire)
18.02.23		ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Establishment Labs Holdings Inc. Investors to Inquire About Securities Class Action Investigation - ESTA (PR Newswire)
13.02.23		Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27 (Businesswire)
09.01.23		Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022 (Businesswire)
03.01.23		Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™ (Businesswire)
28.12.22		Establishment Labs to Participate in 41st Annual J.P. Morgan Healthcare Conference (Businesswire)
10.11.22		Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction (Businesswire)
07.11.22		Establishment Labs Reports Third Quarter 2022 Financial Results (Businesswire)
01.11.22		Establishment Labs Announces Participation in Two Upcoming Investment Conferences (Businesswire)
24.10.22		Establishment Labs to Announce Third Quarter 2022 Financial Results on November 7 (Businesswire)
21.10.22		ESTA INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors with Losses to Inquire About Securities Class Action Investigation - ESTA (PR Newswire)
20.09.22		Establishment Labs to Host Investor Event for Mia Femtech on October 5, 2022 (Businesswire)
12.09.22		Establishment Labs Announces Hani Zeini has Joined the Company as Exclusive Advisor in Anticipation of US Launch (Businesswire)
08.08.22		Establishment Labs Reports Record Second Quarter 2022 Financial Results (Businesswire)
03.08.22		Establishment Labs Announces Complete Enrollment in Motiva US IDE Study (Businesswire)
25.07.22		Establishment Labs to Announce Second Quarter 2022 Financial Results on August 8 (Businesswire)
19.07.22		Establishment Labs Releases 2021 Sustainability Review (Businesswire)
06.06.22		Establishment Labs to Present at the Jefferies Healthcare Conference (Businesswire)
10.05.22		ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2 (RTTNews)
09.05.22		Establishment Labs Reports Record First Quarter 2022 Financial Results (Businesswire)
28.04.22		Establishment Labs to Announce First Quarter 2022 Financial Results on May 9 (Businesswire)
26.04.22		Establishment Labs Enters Into $225 Million Credit Facility With Oaktree (Businesswire)
22.04.22		Establishment Labs Notes Presentation of 2-Year Results from Motiva US IDE Study at The Aesthetic Meeting 2022 (Businesswire)
11.04.22		Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest (Businesswire)
02.03.22		Establishment Labs to Present at the Cowen 42nd Annual Health Care Conference (Businesswire)
01.03.22		Establishment Labs Reports Fourth Quarter and Full Year 2021 Financial Results; Record Fourth Quarter Revenue of $35.3 Million (Businesswire)
17.02.22		Establishment Labs Reaches Two Million Motiva Implants Milestone (Businesswire)
15.02.22		Establishment Labs to Announce Fourth Quarter 2021 Financial Results on March 1 (Businesswire)
10.01.22		Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue (Businesswire)
03.01.22		Establishment Labs to Present at the 40th Annual J.P. Morgan Healthcare Conference (Businesswire)
13.12.21		Establishment Labs Announces Appointment of Raj Denhoy as Chief Financial Officer (Businesswire)
23.06.21		Establishment Labs Breaks Ground on Third Facility, Preparing to Expand Capabilities in Manufacturing, R&D, and Medical Education (Businesswire)
21.06.21		Establishment Labs Announces Publication of Landmark Breast Implant Surface Research in Nature Biomedical Engineering (Businesswire)
25.05.21		Establishment Labs Announces Participation in the Jefferies Virtual Healthcare Conference (Businesswire)
18.05.21		Establishment Labs Announces Pratip Dastidar Has Joined the Company as Head of Global Operations (Businesswire)
11.05.21		Establishment Labs Announces Participation in the UBS Global Healthcare Virtual Conference (Businesswire)
05.05.21		Establishment Labs Reports Record First Quarter 2021 Financial Results and Raises Full Year Guidance (Businesswire)
27.04.21		Establishment Labs Completes Enrollment of One Hundred Patient Motiva Mia IRB Study (Businesswire)
14.04.21		Establishment Labs to Announce First Quarter 2021 Financial Results on May 5 (Businesswire)
10.03.21		Establishment Labs Reports Fourth Quarter and Full Year 2020 Financial Results; Record Fourth Quarter Revenue of $27.0 Million (Businesswire)
24.02.21		Establishment Labs Announces Raj Denhoy Has Joined the Company as Head of Strategy and Investor Relations (Businesswire)
24.02.21		Establishment Labs to Announce Fourth Quarter 2020 Financial Results on March 10 (Businesswire)
16.02.21		Establishment Labs Announces Participation in the Cowen 41st Annual Healthcare Conference (Businesswire)
09.02.21		Establishment Labs Hosts Investor Event for its Motiva MIA® System for Minimally Invasive Augmentation (Businesswire)
03.02.21		Establishment Labs Announces Participation in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference (Businesswire)
21.01.21		Establishment Labs to Host Investor Event Featuring Its Motiva Mia System (Businesswire)
11.01.21		Establishment Labs Reports Preliminary Results for Fourth Quarter and Fiscal Year 2020 (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Pierer Mobility-Aktie schwach: Gehälter für Angestellte von insolventer KTM noch vor Weihnachten

Bundesheer wirbt nach KTM-Insolvenz um Mitarbeiter - Pierer Mobility-Aktie im Plus

Ethereum Kurs Prognose: ETH massiv unterbewertet! Fällt jetzt das ATH?

Zalando-Aktie im Plus, ABOUT YOU-Aktie mit Kurssprung: Zalando unterbreitet Übernahmeangebot für ABOUT YOU

NASDAQ 100: Palantir und MicroStrategy vor der Aufnahme - Was Anleger wissen sollten

TUI-Aktie im Plus: Gewinne dank Urlauber-Ansturm

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	13.12.2024 22:03
Kaufwert:	EUR
	Hinzufügen Speichern